Principles and guidelines for surgeons—management of symptomatic breast cancer
Identifieur interne : 002D28 ( Istex/Corpus ); précédent : 002D27; suivant : 002D29Principles and guidelines for surgeons—management of symptomatic breast cancer
Auteurs : M. Blichert-Toft ; M. G. Smola ; L. Cataliotti ; N. O'HigginsSource :
- European Journal of Surgical Oncology [ 0748-7983 ] ; 1997.
Abstract
The European Society of Surgical Oncology is actively involved in the promotion of a high standard of surgical oncology throughout Europe. Such an ambition involves recognition of Centres of Excellence in the management of cancer patients throughout Europe. These centres have a multi-disciplinary system involved in the total care of patients with cancer and are concerned with the delivery of care to the highest available standards. It is accepted that not all patients with cancer can, nor should, necessarily be treated in such highly specialized centres. Yet all cancer patients should be guaranteed a high standard of care. High surgical standards can be ensured if surgeons treating cancer are trained in specialist centres and, when in independent practice, follow established guidelines or protocols of treatment. In common with many national surgical oncology societies, the European Society of Surgical Oncology is in the process of establishing good practice guidelines in the treatment of solid tumours. This document on the management of symptomatic breast cancer is the first of a series of guidelines to be proposed by ESSO. It draws heavily on excellent documents already in existence from the British Association of Surgical Oncology and from the Danish Breast Cancer Co-Operative Group. It is hoped that this document will be sufficiently clear and purposeful to be of help to the individual surgeon and yet sufficiently flexible to allow it to be adopted in the different medical systems throughout Europe.
Url:
DOI: 10.1016/S0748-7983(97)80001-7
Links to Exploration step
ISTEX:4CA14B6514830F0908CC91146C55ABB34598516BLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Principles and guidelines for surgeons—management of symptomatic breast cancer</title><author><name sortKey="Blichert Toft, M" sort="Blichert Toft, M" uniqKey="Blichert Toft M" first="M." last="Blichert-Toft">M. Blichert-Toft</name><affiliation><mods:affiliation>Department of Surgery, Rigshospitalet, Copenhagen, Denmark</mods:affiliation></affiliation></author><author><name sortKey="Smola, M G" sort="Smola, M G" uniqKey="Smola M" first="M. G." last="Smola">M. G. Smola</name><affiliation><mods:affiliation>Universität Klinik für Chirurgie, Karl Franzens Universität, Graz, Austria</mods:affiliation></affiliation></author><author><name sortKey="Cataliotti, L" sort="Cataliotti, L" uniqKey="Cataliotti L" first="L." last="Cataliotti">L. Cataliotti</name><affiliation><mods:affiliation>Clinica Chirurgica I, University of Florence, Italy</mods:affiliation></affiliation></author><author><name sortKey="O Higgins, N" sort="O Higgins, N" uniqKey="O Higgins N" first="N." last="O'Higgins">N. O'Higgins</name><affiliation><mods:affiliation>University College, Dublin, Ireland</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:4CA14B6514830F0908CC91146C55ABB34598516B</idno><date when="1997" year="1997">1997</date><idno type="doi">10.1016/S0748-7983(97)80001-7</idno><idno type="url">https://api.istex.fr/document/4CA14B6514830F0908CC91146C55ABB34598516B/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">002D28</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002D28</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Principles and guidelines for surgeons—management of symptomatic breast cancer</title><author><name sortKey="Blichert Toft, M" sort="Blichert Toft, M" uniqKey="Blichert Toft M" first="M." last="Blichert-Toft">M. Blichert-Toft</name><affiliation><mods:affiliation>Department of Surgery, Rigshospitalet, Copenhagen, Denmark</mods:affiliation></affiliation></author><author><name sortKey="Smola, M G" sort="Smola, M G" uniqKey="Smola M" first="M. G." last="Smola">M. G. Smola</name><affiliation><mods:affiliation>Universität Klinik für Chirurgie, Karl Franzens Universität, Graz, Austria</mods:affiliation></affiliation></author><author><name sortKey="Cataliotti, L" sort="Cataliotti, L" uniqKey="Cataliotti L" first="L." last="Cataliotti">L. Cataliotti</name><affiliation><mods:affiliation>Clinica Chirurgica I, University of Florence, Italy</mods:affiliation></affiliation></author><author><name sortKey="O Higgins, N" sort="O Higgins, N" uniqKey="O Higgins N" first="N." last="O'Higgins">N. O'Higgins</name><affiliation><mods:affiliation>University College, Dublin, Ireland</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">European Journal of Surgical Oncology</title><title level="j" type="abbrev">YEJSO</title><idno type="ISSN">0748-7983</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="1997">1997</date><biblScope unit="volume">23</biblScope><biblScope unit="issue">2</biblScope><biblScope unit="page" from="101">101</biblScope><biblScope unit="page" to="109">109</biblScope></imprint><idno type="ISSN">0748-7983</idno></series><idno type="istex">4CA14B6514830F0908CC91146C55ABB34598516B</idno><idno type="DOI">10.1016/S0748-7983(97)80001-7</idno><idno type="PII">S0748-7983(97)80001-7</idno><idno type="ArticleID">97800017</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0748-7983</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The European Society of Surgical Oncology is actively involved in the promotion of a high standard of surgical oncology throughout Europe. Such an ambition involves recognition of Centres of Excellence in the management of cancer patients throughout Europe. These centres have a multi-disciplinary system involved in the total care of patients with cancer and are concerned with the delivery of care to the highest available standards. It is accepted that not all patients with cancer can, nor should, necessarily be treated in such highly specialized centres. Yet all cancer patients should be guaranteed a high standard of care. High surgical standards can be ensured if surgeons treating cancer are trained in specialist centres and, when in independent practice, follow established guidelines or protocols of treatment. In common with many national surgical oncology societies, the European Society of Surgical Oncology is in the process of establishing good practice guidelines in the treatment of solid tumours. This document on the management of symptomatic breast cancer is the first of a series of guidelines to be proposed by ESSO. It draws heavily on excellent documents already in existence from the British Association of Surgical Oncology and from the Danish Breast Cancer Co-Operative Group. It is hoped that this document will be sufficiently clear and purposeful to be of help to the individual surgeon and yet sufficiently flexible to allow it to be adopted in the different medical systems throughout Europe.</div></front></TEI><istex><corpusName>elsevier</corpusName><author><json:item><name>M. Blichert-Toft</name><affiliations><json:string>Department of Surgery, Rigshospitalet, Copenhagen, Denmark</json:string></affiliations></json:item><json:item><name>M.G. Smola</name><affiliations><json:string>Universität Klinik für Chirurgie, Karl Franzens Universität, Graz, Austria</json:string></affiliations></json:item><json:item><name>L. Cataliotti</name><affiliations><json:string>Clinica Chirurgica I, University of Florence, Italy</json:string></affiliations></json:item><json:item><name>N. O'Higgins</name><affiliations><json:string>University College, Dublin, Ireland</json:string></affiliations></json:item></author><articleId><json:string>97800017</json:string></articleId><language><json:string>eng</json:string></language><abstract>The European Society of Surgical Oncology is actively involved in the promotion of a high standard of surgical oncology throughout Europe. Such an ambition involves recognition of Centres of Excellence in the management of cancer patients throughout Europe. These centres have a multi-disciplinary system involved in the total care of patients with cancer and are concerned with the delivery of care to the highest available standards. It is accepted that not all patients with cancer can, nor should, necessarily be treated in such highly specialized centres. Yet all cancer patients should be guaranteed a high standard of care. High surgical standards can be ensured if surgeons treating cancer are trained in specialist centres and, when in independent practice, follow established guidelines or protocols of treatment. In common with many national surgical oncology societies, the European Society of Surgical Oncology is in the process of establishing good practice guidelines in the treatment of solid tumours. This document on the management of symptomatic breast cancer is the first of a series of guidelines to be proposed by ESSO. It draws heavily on excellent documents already in existence from the British Association of Surgical Oncology and from the Danish Breast Cancer Co-Operative Group. It is hoped that this document will be sufficiently clear and purposeful to be of help to the individual surgeon and yet sufficiently flexible to allow it to be adopted in the different medical systems throughout Europe.</abstract><qualityIndicators><score>7.844</score><pdfVersion>1.3</pdfVersion><pdfPageSize>648 x 864 pts</pdfPageSize><refBibsNative>true</refBibsNative><keywordCount>0</keywordCount><abstractCharCount>1527</abstractCharCount><pdfWordCount>5904</pdfWordCount><pdfCharCount>38251</pdfCharCount><pdfPageCount>9</pdfPageCount><abstractWordCount>237</abstractWordCount></qualityIndicators><title>Principles and guidelines for surgeons—management of symptomatic breast cancer</title><pii><json:string>S0748-7983(97)80001-7</json:string></pii><genre><json:string>review-article</json:string></genre><serie><editor><json:item><name>A Engeland</name></json:item><json:item><name>T Haldorsen</name></json:item><json:item><name>S Tretli</name></json:item></editor><pages><last>74</last><first>72</first></pages><genre></genre><language><json:string>unknown</json:string></language><title>Prediction of Cancer Mortality in the Nordic Countries up to the Years 2000 and 2010, on the Basis of Relative Survival Analysis</title></serie><host><volume>23</volume><pii><json:string>S0748-7983(00)X0073-X</json:string></pii><pages><last>109</last><first>101</first></pages><issn><json:string>0748-7983</json:string></issn><issue>2</issue><genre><json:string>Journal</json:string></genre><language><json:string>unknown</json:string></language><title>European Journal of Surgical Oncology</title><publicationDate>1997</publicationDate></host><categories><wos><json:string>ONCOLOGY</json:string><json:string>SURGERY</json:string></wos></categories><publicationDate>1997</publicationDate><copyrightDate>1997</copyrightDate><doi><json:string>10.1016/S0748-7983(97)80001-7</json:string></doi><id>4CA14B6514830F0908CC91146C55ABB34598516B</id><score>1</score><fulltext><json:item><original>true</original><mimetype>application/pdf</mimetype><extension>pdf</extension><uri>https://api.istex.fr/document/4CA14B6514830F0908CC91146C55ABB34598516B/fulltext/pdf</uri></json:item><json:item><original>true</original><mimetype>text/plain</mimetype><extension>txt</extension><uri>https://api.istex.fr/document/4CA14B6514830F0908CC91146C55ABB34598516B/fulltext/txt</uri></json:item><json:item><original>false</original><mimetype>application/zip</mimetype><extension>zip</extension><uri>https://api.istex.fr/document/4CA14B6514830F0908CC91146C55ABB34598516B/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/4CA14B6514830F0908CC91146C55ABB34598516B/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Principles and guidelines for surgeons—management of symptomatic breast cancer</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>ELSEVIER</publisher><availability><p>ELSEVIER</p></availability><date>1997</date></publicationStmt><notesStmt><note>On behalf of the European Society of Surgical Oncology</note><note type="content">Section title: Review</note></notesStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Principles and guidelines for surgeons—management of symptomatic breast cancer</title><author><persName><forename type="first">M.</forename><surname>Blichert-Toft</surname></persName><affiliation>Department of Surgery, Rigshospitalet, Copenhagen, Denmark</affiliation></author><author><persName><forename type="first">M.G.</forename><surname>Smola</surname></persName><affiliation>Universität Klinik für Chirurgie, Karl Franzens Universität, Graz, Austria</affiliation></author><author><persName><forename type="first">L.</forename><surname>Cataliotti</surname></persName><affiliation>Clinica Chirurgica I, University of Florence, Italy</affiliation></author><author><persName><forename type="first">N.</forename><surname>O'Higgins</surname></persName><affiliation>University College, Dublin, Ireland</affiliation></author></analytic><monogr><title level="j">European Journal of Surgical Oncology</title><title level="j" type="abbrev">YEJSO</title><idno type="pISBN">87-89638-39-5</idno><idno type="pISSN">0748-7983</idno><idno type="PII">S0748-7983(00)X0073-X</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="1997"></date><biblScope unit="volume">23</biblScope><biblScope unit="issue">2</biblScope><biblScope unit="page" from="101">101</biblScope><biblScope unit="page" to="109">109</biblScope></imprint></monogr><idno type="istex">4CA14B6514830F0908CC91146C55ABB34598516B</idno><idno type="DOI">10.1016/S0748-7983(97)80001-7</idno><idno type="PII">S0748-7983(97)80001-7</idno><idno type="ArticleID">97800017</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>1997</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>The European Society of Surgical Oncology is actively involved in the promotion of a high standard of surgical oncology throughout Europe. Such an ambition involves recognition of Centres of Excellence in the management of cancer patients throughout Europe. These centres have a multi-disciplinary system involved in the total care of patients with cancer and are concerned with the delivery of care to the highest available standards. It is accepted that not all patients with cancer can, nor should, necessarily be treated in such highly specialized centres. Yet all cancer patients should be guaranteed a high standard of care. High surgical standards can be ensured if surgeons treating cancer are trained in specialist centres and, when in independent practice, follow established guidelines or protocols of treatment. In common with many national surgical oncology societies, the European Society of Surgical Oncology is in the process of establishing good practice guidelines in the treatment of solid tumours. This document on the management of symptomatic breast cancer is the first of a series of guidelines to be proposed by ESSO. It draws heavily on excellent documents already in existence from the British Association of Surgical Oncology and from the Danish Breast Cancer Co-Operative Group. It is hoped that this document will be sufficiently clear and purposeful to be of help to the individual surgeon and yet sufficiently flexible to allow it to be adopted in the different medical systems throughout Europe.</p></abstract></profileDesc><revisionDesc><change when="1997">Published</change></revisionDesc></teiHeader></istex:fulltextTEI></fulltext><metadata><istex:metadataXml wicri:clean="Elsevier doc found" wicri:toSee="Elsevier, no converted or simple article"><istex:xmlDeclaration>version="1.0" encoding="utf-8"</istex:xmlDeclaration><istex:docType PUBLIC="-//ES//DTD journal article DTD version 5.0.1//EN//XML" URI="art501.dtd" name="istex:docType"></istex:docType><istex:document><article version="5.0" xml:lang="en" docsubtype="rev"><item-info><jid>YEJSO</jid><aid>97800017</aid><ce:pii>S0748-7983(97)80001-7</ce:pii><ce:doi>10.1016/S0748-7983(97)80001-7</ce:doi><ce:copyright type="unknown" year="1997">W.B. Saunders Company Limited</ce:copyright></item-info><head><ce:dochead><ce:textfn>Review</ce:textfn></ce:dochead><ce:title>Principles and guidelines for surgeons—management of symptomatic breast cancer</ce:title><ce:author-group><ce:author><ce:given-name>M.</ce:given-name><ce:surname>Blichert-Toft</ce:surname><ce:cross-ref refid="aff1"><ce:sup>*</ce:sup></ce:cross-ref></ce:author><ce:author><ce:given-name>M.G.</ce:given-name><ce:surname>Smola</ce:surname><ce:cross-ref refid="aff2"><ce:sup>†</ce:sup></ce:cross-ref></ce:author><ce:author><ce:given-name>L.</ce:given-name><ce:surname>Cataliotti</ce:surname><ce:cross-ref refid="aff3"><ce:sup>‡</ce:sup></ce:cross-ref></ce:author><ce:author><ce:given-name>N.</ce:given-name><ce:surname>O'Higgins</ce:surname><ce:cross-ref refid="aff4"><ce:sup>§</ce:sup></ce:cross-ref></ce:author><ce:affiliation id="aff1"><ce:label>*</ce:label><ce:textfn>Department of Surgery, Rigshospitalet, Copenhagen, Denmark</ce:textfn></ce:affiliation><ce:affiliation id="aff2"><ce:label>†</ce:label><ce:textfn>Universität Klinik für Chirurgie, Karl Franzens Universität, Graz, Austria</ce:textfn></ce:affiliation><ce:affiliation id="aff3"><ce:label>‡</ce:label><ce:textfn>Clinica Chirurgica I, University of Florence, Italy</ce:textfn></ce:affiliation><ce:affiliation id="aff4"><ce:label>§</ce:label><ce:textfn>University College, Dublin, Ireland</ce:textfn></ce:affiliation></ce:author-group><ce:miscellaneous>On behalf of the European Society of Surgical Oncology</ce:miscellaneous><ce:abstract id="ab1" class="author" xml:lang="en"><ce:abstract-sec><ce:simple-para>The European Society of Surgical Oncology is actively involved in the promotion of a high standard of surgical oncology throughout Europe. Such an ambition involves recognition of Centres of Excellence in the management of cancer patients throughout Europe. These centres have a multi-disciplinary system involved in the total care of patients with cancer and are concerned with the delivery of care to the highest available standards. It is accepted that not all patients with cancer can, nor should, necessarily be treated in such highly specialized centres. Yet all cancer patients should be guaranteed a high standard of care. High surgical standards can be ensured if surgeons treating cancer are trained in specialist centres and, when in independent practice, follow established guidelines or protocols of treatment. In common with many national surgical oncology societies, the European Society of Surgical Oncology is in the process of establishing good practice guidelines in the treatment of solid tumours. This document on the management of symptomatic breast cancer is the first of a series of guidelines to be proposed by ESSO. It draws heavily on excellent documents already in existence from the British Association of Surgical Oncology and from the Danish Breast Cancer Co-Operative Group. It is hoped that this document will be sufficiently clear and purposeful to be of help to the individual surgeon and yet sufficiently flexible to allow it to be adopted in the different medical systems throughout Europe.</ce:simple-para></ce:abstract-sec></ce:abstract></head><tail><ce:bibliography><ce:section-title>References</ce:section-title><ce:bibliography-sec><ce:bib-reference id="bib1"><ce:label>1.</ce:label><sb:reference><sb:contribution langtype="en"><sb:authors><sb:author><ce:surname>van Dongen</ce:surname><ce:given-name>JA</ce:given-name></sb:author></sb:authors><sb:title><sb:maintitle>Present and future state of surgical management in breast cancer</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Eur J Surg</sb:maintitle></sb:title><sb:volume-nr>162</sb:volume-nr></sb:series><sb:date>1996</sb:date></sb:issue><sb:pages><sb:first-page>87</sb:first-page><sb:last-page>91</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib2"><ce:label>2.</ce:label><sb:reference><sb:contribution langtype="en"><sb:authors><sb:author><ce:surname>Baum</ce:surname><ce:given-name>M</ce:given-name></sb:author></sb:authors><sb:title><sb:maintitle>Breast cancer 2000 BC to 2000AD—Time for a paradigm shift?</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Acta Oncol</sb:maintitle></sb:title><sb:volume-nr>32</sb:volume-nr></sb:series><sb:date>1993</sb:date></sb:issue><sb:pages><sb:first-page>3</sb:first-page><sb:last-page>8</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib3"><ce:label>3.</ce:label><sb:reference><sb:contribution langtype="en"><sb:authors><sb:author><ce:surname>Eindhoven Cancer Registry</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Breast cancer</sb:maintitle></sb:title></sb:contribution><sb:host><sb:edited-book><sb:editors><sb:editor><ce:surname>Coeberg</ce:surname><ce:given-name>JWW</ce:given-name></sb:editor><sb:editor><ce:surname>Heijden LH</ce:surname><ce:given-name>van der</ce:given-name></sb:editor><sb:editor><ce:surname>Janssen-Heijnen</ce:surname><ce:given-name>MLG</ce:given-name></sb:editor></sb:editors><sb:title><sb:maintitle>Cancer Incidence and Survival in the Southeast of the Netherlands</sb:maintitle></sb:title><sb:date>1995</sb:date><sb:publisher><sb:name>IKZ</sb:name></sb:publisher></sb:edited-book><sb:pages><sb:first-page>54</sb:first-page><sb:last-page>56</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib4"><ce:label>4.</ce:label><sb:reference><sb:contribution langtype="en"><sb:authors><sb:author><ce:surname>Ewertz</ce:surname><ce:given-name>M</ce:given-name></sb:author></sb:authors><sb:title><sb:maintitle>Breast Cancer in Denmark Incidence, Risk Factors, and Characteristics of Survival</sb:maintitle></sb:title></sb:contribution><sb:host><sb:edited-book><sb:date>1993</sb:date><sb:publisher><sb:name>DataGraf Auning AS</sb:name><sb:location>Eindhoven</sb:location></sb:publisher></sb:edited-book><sb:pages><sb:first-page>7</sb:first-page><sb:last-page>27</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib5"><ce:label>5.</ce:label><sb:reference><sb:comment>(Suppl. 49)</sb:comment><sb:contribution langtype="en"><sb:authors><sb:author><ce:surname>Association of the Nordic Cancer Registries</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Cancer of the breast. Females</sb:maintitle></sb:title></sb:contribution><sb:host><sb:edited-book><sb:editors><sb:editor><ce:surname>Engeland</ce:surname><ce:given-name>A</ce:given-name></sb:editor><sb:editor><ce:surname>Haldorsen</ce:surname><ce:given-name>T</ce:given-name></sb:editor><sb:editor><ce:surname>Tretli</ce:surname><ce:given-name>S</ce:given-name></sb:editor><sb:et-al></sb:et-al></sb:editors><sb:title><sb:maintitle>Prediction of Cancer Mortality in the Nordic Countries up to the Years 2000 and 2010, on the Basis of Relative Survival Analysis</sb:maintitle></sb:title><sb:book-series><sb:series><sb:title><sb:maintitle>APMIS</sb:maintitle></sb:title><sb:volume-nr>103</sb:volume-nr></sb:series></sb:book-series><sb:date>1995</sb:date></sb:edited-book><sb:pages><sb:first-page>72</sb:first-page><sb:last-page>74</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib6"><ce:label>6.</ce:label><sb:reference><sb:contribution langtype="en"><sb:authors><sb:author><ce:surname>Micheli</ce:surname><ce:given-name>A</ce:given-name></sb:author><sb:author><ce:surname>Verdecchia</ce:surname><ce:given-name>A</ce:given-name></sb:author><sb:author><ce:surname>Capocaccia</ce:surname><ce:given-name>R</ce:given-name></sb:author><sb:et-al></sb:et-al></sb:authors><sb:title><sb:maintitle>Estimated incidence and prevalence of female breast cancer in Italian regions</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Tumori</sb:maintitle></sb:title><sb:volume-nr>78</sb:volume-nr></sb:series><sb:date>1992</sb:date></sb:issue><sb:pages><sb:first-page>13</sb:first-page><sb:last-page>21</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib7"><ce:label>7.</ce:label><sb:reference><sb:contribution langtype="en"><sb:authors><sb:author><ce:surname>Andreasen</ce:surname><ce:given-name>AH</ce:given-name></sb:author><sb:author><ce:surname>Mouridsen</ce:surname><ce:given-name>HT</ce:given-name></sb:author><sb:author><ce:surname>Andersen</ce:surname><ce:given-name>KW</ce:given-name></sb:author><sb:author><ce:surname>Lynge</ce:surname><ce:given-name>E</ce:given-name></sb:author><sb:author><ce:surname>Madsen</ce:surname><ce:given-name>M</ce:given-name></sb:author><sb:author><ce:surname>Olesen</ce:surname><ce:given-name>KP</ce:given-name></sb:author></sb:authors><sb:title><sb:maintitle>Equity and improvement in outcome of breast cancer in Denmark</sb:maintitle></sb:title></sb:contribution><sb:host><sb:edited-book><sb:editors><sb:editor><ce:surname>France</ce:surname><ce:given-name>FHR</ce:given-name></sb:editor><sb:editor><ce:surname>Goor JN</ce:surname><ce:given-name>van</ce:given-name></sb:editor><sb:editor><ce:surname>Johansen</ce:surname><ce:given-name>KS</ce:given-name></sb:editor></sb:editors><sb:title><sb:maintitle>Case-based Telematic Systems towards Equity in Health Care</sb:maintitle></sb:title><sb:date>1994</sb:date><sb:publisher><sb:name>IOS Press</sb:name><sb:location>Copenhagen</sb:location></sb:publisher></sb:edited-book><sb:pages><sb:first-page>27</sb:first-page><sb:last-page>38</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib8"><ce:label>8.</ce:label><sb:reference><sb:contribution langtype="en"><sb:authors><sb:author><ce:surname>Eberlein</ce:surname><ce:given-name>TJ</ce:given-name></sb:author></sb:authors><sb:title><sb:maintitle>Preoperative chemotherapy: where do we go from here</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Ann Surg</sb:maintitle></sb:title><sb:volume-nr>222</sb:volume-nr></sb:series><sb:date>1995</sb:date></sb:issue><sb:pages><sb:first-page>609</sb:first-page><sb:last-page>611</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib9"><ce:label>9.</ce:label><sb:reference><sb:contribution langtype="en"><sb:authors><sb:author><ce:surname>Saran</ce:surname><ce:given-name>P</ce:given-name></sb:author><sb:author><ce:surname>Bord</ce:surname><ce:given-name>MA</ce:given-name></sb:author></sb:authors><sb:title><sb:maintitle>Multi-disciplinary breast cancer center: experience at the University of Michigan</sb:maintitle></sb:title></sb:contribution><sb:host><sb:edited-book><sb:editors><sb:editor><ce:surname>Harness</ce:surname><ce:given-name>JK</ce:given-name></sb:editor><sb:editor><ce:surname>Oberman</ce:surname><ce:given-name>HA</ce:given-name></sb:editor><sb:editor><ce:surname>Lichter</ce:surname><ce:given-name>AS</ce:given-name></sb:editor><sb:editor><ce:surname>Adler</ce:surname><ce:given-name>DD</ce:given-name></sb:editor><sb:editor><ce:surname>Cody</ce:surname><ce:given-name>RL</ce:given-name></sb:editor></sb:editors><sb:title><sb:maintitle>Breast Cancer</sb:maintitle></sb:title><sb:book-series><sb:series><sb:title><sb:maintitle>Collaborative Management</sb:maintitle></sb:title></sb:series></sb:book-series><sb:date>1988</sb:date><sb:publisher><sb:name>Lewis Publishers</sb:name><sb:location>Amsterdam</sb:location></sb:publisher></sb:edited-book><sb:pages><sb:first-page>265</sb:first-page><sb:last-page>272</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib10"><ce:label>10.</ce:label><sb:reference><sb:contribution langtype="en"><sb:authors><sb:collaboration>The Breast Surgeons Group of the British Association of Surgical Oncology</sb:collaboration></sb:authors><sb:title><sb:maintitle>Guidelines for surgeons in the management of symptomatic breast disease in the United Kingdom</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Eur J Surg Oncol</sb:maintitle></sb:title><sb:volume-nr>21</sb:volume-nr></sb:series><sb:issue-nr>Suppl. A</sb:issue-nr><sb:date>1995</sb:date></sb:issue><sb:pages><sb:first-page>1</sb:first-page><sb:last-page>13</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib11"><ce:label>11.</ce:label><sb:reference><sb:contribution langtype="en"><sb:authors><sb:author><ce:surname>Paci</ce:surname><ce:given-name>E</ce:given-name></sb:author><sb:author><ce:surname>Zappa</ce:surname><ce:given-name>M</ce:given-name></sb:author><sb:author><ce:surname>Palli</ce:surname><ce:given-name>D</ce:given-name></sb:author><sb:author><ce:surname>Girogi</ce:surname><ce:given-name>D</ce:given-name></sb:author><sb:author><ce:surname>Cariddi</ce:surname><ce:given-name>A</ce:given-name></sb:author><sb:et-al></sb:et-al></sb:authors><sb:title><sb:maintitle>Changes in stage and treatment of breast cancer in Florence from 1985–1990</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>The Breast</sb:maintitle></sb:title><sb:volume-nr>3</sb:volume-nr></sb:series><sb:date>1994</sb:date></sb:issue><sb:pages><sb:first-page>109</sb:first-page><sb:last-page>112</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib12"><ce:label>12.</ce:label><sb:reference><sb:contribution langtype="en"><sb:authors><sb:author><ce:surname>Gillis</ce:surname><ce:given-name>CR</ce:given-name></sb:author><sb:author><ce:surname>Hole</ce:surname><ce:given-name>DJ</ce:given-name></sb:author></sb:authors><sb:title><sb:maintitle>Survival outcome of care by specialist surgeons in breast cancer: a study of 3786 patients in the west of Scotland</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Br Med J</sb:maintitle></sb:title><sb:volume-nr>312</sb:volume-nr></sb:series><sb:date>1996</sb:date></sb:issue><sb:pages><sb:first-page>145</sb:first-page><sb:last-page>148</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib13"><ce:label>13.</ce:label><sb:reference><sb:contribution langtype="en"><sb:authors><sb:author><ce:surname>Blichert-Toft</ce:surname><ce:given-name>M</ce:given-name></sb:author><sb:author><ce:surname>Mouridsen</ce:surname><ce:given-name>HT</ce:given-name></sb:author><sb:author><ce:surname>Andersen</ce:surname><ce:given-name>KW</ce:given-name></sb:author></sb:authors><sb:title><sb:maintitle>Clinical trials</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Sem Surg Oncol</sb:maintitle></sb:title><sb:volume-nr>12</sb:volume-nr></sb:series><sb:date>1996</sb:date></sb:issue><sb:pages><sb:first-page>32</sb:first-page><sb:last-page>38</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib14"><ce:label>14.</ce:label><sb:reference><sb:contribution langtype="en"><sb:authors><sb:author><ce:surname>Yusuf</ce:surname><ce:given-name>S</ce:given-name></sb:author><sb:author><ce:surname>Collins</ce:surname><ce:given-name>R</ce:given-name></sb:author><sb:author><ce:surname>Peto</ce:surname><ce:given-name>R</ce:given-name></sb:author></sb:authors><sb:title><sb:maintitle>Why do we need some large, simple randomized trials?</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Stat Med</sb:maintitle></sb:title><sb:volume-nr>3</sb:volume-nr></sb:series><sb:date>1984</sb:date></sb:issue><sb:pages><sb:first-page>409</sb:first-page><sb:last-page>422</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib15"><ce:label>15.</ce:label><sb:reference><sb:comment>Report</sb:comment><sb:contribution langtype="en"><sb:authors><sb:author><ce:surname>The Danish National Health Board</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Brystkraeft—Tidlig opsporing og undersøgelse</sb:maintitle></sb:title></sb:contribution><sb:comment>Copenhagen</sb:comment><sb:host><sb:edited-book><sb:date>1994</sb:date><sb:isbn>87-89638-39-5</sb:isbn></sb:edited-book><sb:pages><sb:first-page>1</sb:first-page><sb:last-page>144</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib16"><ce:label>16.</ce:label><sb:reference><sb:contribution langtype="en"><sb:authors><sb:author><ce:surname>Blichert-Toft</ce:surname><ce:given-name>M</ce:given-name></sb:author><sb:author><ce:surname>Dyreborg</ce:surname><ce:given-name>U</ce:given-name></sb:author><sb:author><ce:surname>Andersen</ce:surname><ce:given-name>J</ce:given-name></sb:author></sb:authors><sb:title><sb:maintitle>Diagnostic strategy in the management of patients with breast symptoms</sb:maintitle></sb:title></sb:contribution><sb:host><sb:edited-book><sb:title><sb:maintitle>A recommended design and present experience</sb:maintitle></sb:title><sb:book-series><sb:series><sb:title><sb:maintitle>Acta Oncol</sb:maintitle></sb:title><sb:volume-nr>27</sb:volume-nr></sb:series></sb:book-series><sb:date>1988</sb:date></sb:edited-book><sb:pages><sb:first-page>597</sb:first-page><sb:last-page>600</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib17"><ce:label>17.</ce:label><sb:reference><sb:contribution langtype="en"><sb:authors><sb:collaboration>Danish Breast Cancer Co-Operative Group</sb:collaboration></sb:authors></sb:contribution><sb:host><sb:edited-book><sb:book-series><sb:series><sb:title><sb:maintitle>DBCG Protocol Collection 1989</sb:maintitle></sb:title><sb:volume-nr>3</sb:volume-nr></sb:series></sb:book-series><sb:date>1989</sb:date><sb:publisher><sb:name>Rigshospitalet</sb:name><sb:location>Michigan</sb:location></sb:publisher></sb:edited-book><sb:pages><sb:first-page>1</sb:first-page><sb:last-page>179</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib18"><ce:label>18.</ce:label><sb:reference><sb:contribution langtype="en"><sb:authors><sb:author><ce:surname>van Dongen</ce:surname><ce:given-name>JA</ce:given-name></sb:author></sb:authors><sb:title><sb:maintitle>Early breast cancer</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Acta Oncol</sb:maintitle></sb:title><sb:volume-nr>28</sb:volume-nr></sb:series><sb:date>1989</sb:date></sb:issue><sb:pages><sb:first-page>123</sb:first-page><sb:last-page>134</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib19"><ce:label>19.</ce:label><sb:reference><sb:contribution langtype="en"><sb:authors><sb:author><ce:surname>Balch</ce:surname><ce:given-name>CM</ce:given-name></sb:author><sb:author><ce:surname>Singletary</ce:surname><ce:given-name>SE</ce:given-name></sb:author><sb:author><ce:surname>Bland</ce:surname><ce:given-name>KI</ce:given-name></sb:author></sb:authors><sb:title><sb:maintitle>Clinical decision-making in early breast cancer</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Ann Surg</sb:maintitle></sb:title><sb:volume-nr>217</sb:volume-nr></sb:series><sb:date>1993</sb:date></sb:issue><sb:pages><sb:first-page>207</sb:first-page><sb:last-page>225</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib20"><ce:label>20.</ce:label><sb:reference><sb:contribution langtype="en"><sb:authors><sb:author><ce:surname>Tubiana</ce:surname><ce:given-name>M</ce:given-name></sb:author><sb:author><ce:surname>Holland</ce:surname><ce:given-name>R</ce:given-name></sb:author><sb:author><ce:surname>Kopans</ce:surname><ce:given-name>DB</ce:given-name></sb:author><sb:et-al></sb:et-al></sb:authors><sb:title><sb:maintitle>Management of non-palpable and small lesions found in mass breast screening</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Eur J Cancer</sb:maintitle></sb:title><sb:volume-nr>30A</sb:volume-nr></sb:series><sb:date>1994</sb:date></sb:issue><sb:pages><sb:first-page>538</sb:first-page><sb:last-page>547</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib21"><ce:label>21.</ce:label><sb:reference><sb:contribution langtype="en"><sb:authors><sb:author><ce:surname>Ciatto</ce:surname><ce:given-name>S</ce:given-name></sb:author><sb:author><ce:surname>Rosselli</ce:surname><ce:given-name>Del Turco M</ce:given-name></sb:author><sb:et-al></sb:et-al></sb:authors><sb:title><sb:maintitle>Non palpable lesions of the breast detected by mammography</sb:maintitle></sb:title></sb:contribution><sb:host><sb:edited-book><sb:title><sb:maintitle>Review of 1182 consecutive histologically confirmed cases</sb:maintitle></sb:title><sb:book-series><sb:series><sb:title><sb:maintitle>Eur J Cancer</sb:maintitle></sb:title><sb:volume-nr>30A</sb:volume-nr></sb:series></sb:book-series><sb:date>1994</sb:date></sb:edited-book><sb:pages><sb:first-page>40</sb:first-page><sb:last-page>44</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib22"><ce:label>22.</ce:label><sb:reference><sb:contribution langtype="en"><sb:authors><sb:author><ce:surname>Azavedo</ce:surname><ce:given-name>E</ce:given-name></sb:author><sb:author><ce:surname>Cataliotti</ce:surname><ce:given-name>L</ce:given-name></sb:author><sb:author><ce:surname>Ciatto</ce:surname><ce:given-name>S</ce:given-name></sb:author><sb:author><ce:surname>Perry</ce:surname><ce:given-name>N</ce:given-name></sb:author><sb:author><ce:surname>Svane</ce:surname><ce:given-name>G</ce:given-name></sb:author><sb:author><ce:surname>Vielh</ce:surname><ce:given-name>P</ce:given-name></sb:author><sb:collaboration>European Society of Mastology Study Group on detection and diagnosis</sb:collaboration></sb:authors></sb:contribution><sb:host><sb:edited-book><sb:title><sb:maintitle>Proceedings of the EUSOMA seminar on non palpable breast lesions 18th June 1993. Recommendations for the management of non palpable lesions detected by mammography</sb:maintitle></sb:title><sb:book-series><sb:series><sb:title><sb:maintitle>The Breast</sb:maintitle></sb:title><sb:volume-nr>3</sb:volume-nr></sb:series></sb:book-series><sb:date>1994</sb:date></sb:edited-book><sb:pages><sb:first-page>241</sb:first-page><sb:last-page>245</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib23"><ce:label>23.</ce:label><sb:reference><sb:contribution langtype="en"><sb:authors><sb:author><ce:surname>Olsson</ce:surname><ce:given-name>H</ce:given-name></sb:author><sb:author><ce:surname>Borg</ce:surname><ce:given-name>A</ce:given-name></sb:author></sb:authors><sb:title><sb:maintitle>Genetic predisposition to breast cancer</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Acta Oncol</sb:maintitle></sb:title><sb:volume-nr>35</sb:volume-nr></sb:series><sb:date>1996</sb:date></sb:issue><sb:pages><sb:first-page>1</sb:first-page><sb:last-page>8</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib24"><ce:label>24.</ce:label><sb:reference><sb:contribution langtype="en"><sb:authors><sb:author><ce:surname>Veronesi</ce:surname><ce:given-name>U</ce:given-name></sb:author><sb:author><ce:surname>Salvadori</ce:surname><ce:given-name>B</ce:given-name></sb:author><sb:author><ce:surname>Luini</ce:surname><ce:given-name>A</ce:given-name></sb:author><sb:et-al></sb:et-al></sb:authors><sb:title><sb:maintitle>Breast conservation is a safe method in patients with small cancer of the breast</sb:maintitle></sb:title></sb:contribution><sb:host><sb:edited-book><sb:title><sb:maintitle>Long-term results of three randomised trials on 1,973 patients</sb:maintitle></sb:title><sb:book-series><sb:series><sb:title><sb:maintitle>Eur J Cancer</sb:maintitle></sb:title><sb:volume-nr>31A</sb:volume-nr></sb:series></sb:book-series><sb:date>1995</sb:date></sb:edited-book><sb:pages><sb:first-page>1574</sb:first-page><sb:last-page>1579</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib25"><ce:label>25.</ce:label><sb:reference><sb:contribution langtype="en"><sb:authors><sb:author><ce:surname>Sacks</ce:surname><ce:given-name>NPM</ce:given-name></sb:author><sb:author><ce:surname>Barr</ce:surname><ce:given-name>LC</ce:given-name></sb:author><sb:author><ce:surname>Allan</ce:surname><ce:given-name>SM</ce:given-name></sb:author><sb:author><ce:surname>Baum</ce:surname><ce:given-name>M</ce:given-name></sb:author></sb:authors><sb:title><sb:maintitle>The role of axillary dissection in operable breast cancer</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>The Breast</sb:maintitle></sb:title><sb:volume-nr>1</sb:volume-nr></sb:series><sb:date>1992</sb:date></sb:issue><sb:pages><sb:first-page>41</sb:first-page><sb:last-page>49</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib26"><ce:label>26.</ce:label><sb:reference><sb:contribution langtype="en"><sb:authors><sb:author><ce:surname>Graversen</ce:surname><ce:given-name>HP</ce:given-name></sb:author><sb:author><ce:surname>Blichert-Toft</ce:surname><ce:given-name>M</ce:given-name></sb:author><sb:author><ce:surname>Andersen</ce:surname><ce:given-name>JA</ce:given-name></sb:author><sb:author><ce:surname>Zedeler</ce:surname><ce:given-name>K</ce:given-name></sb:author></sb:authors><sb:title><sb:maintitle>Breast cancer: risk of axillary recurrence in node-negative patients following partial dissection of the axilla</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Eur J Surg Oncol</sb:maintitle></sb:title><sb:volume-nr>14</sb:volume-nr></sb:series><sb:date>1988</sb:date></sb:issue><sb:pages><sb:first-page>407</sb:first-page><sb:last-page>412</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib27"><ce:label>27.</ce:label><sb:reference><sb:contribution langtype="en"><sb:authors><sb:author><ce:surname>Axelsson</ce:surname><ce:given-name>CK</ce:given-name></sb:author><sb:author><ce:surname>Mouridsen</ce:surname><ce:given-name>HT</ce:given-name></sb:author><sb:author><ce:surname>Zedeler</ce:surname><ce:given-name>K</ce:given-name></sb:author></sb:authors><sb:title><sb:maintitle>Axillary dissection of level I and ll lymph nodes is important in breast cancer classification</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Eur J Cancer</sb:maintitle></sb:title><sb:volume-nr>28A</sb:volume-nr></sb:series><sb:date>1992</sb:date></sb:issue><sb:pages><sb:first-page>1415</sb:first-page><sb:last-page>1418</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib28"><ce:label>28.</ce:label><sb:reference><sb:contribution langtype="en"><sb:authors><sb:author><ce:surname>Wilking</ce:surname><ce:given-name>N</ce:given-name></sb:author><sb:author><ce:surname>Rutqvist</ce:surname><ce:given-name>LE</ce:given-name></sb:author><sb:author><ce:surname>Carstensen</ce:surname><ce:given-name>J</ce:given-name></sb:author><sb:author><ce:surname>Mattsson</ce:surname><ce:given-name>A</ce:given-name></sb:author><sb:author><ce:surname>Skoog</ce:surname><ce:given-name>L</ce:given-name></sb:author></sb:authors><sb:title><sb:maintitle>Prognostic significance of axillary nodal status in primary breast cancer in relation to the number of resected nodes</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Acta Oncol</sb:maintitle></sb:title><sb:volume-nr>31</sb:volume-nr></sb:series><sb:date>1992</sb:date></sb:issue><sb:pages><sb:first-page>29</sb:first-page><sb:last-page>35</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib29"><ce:label>29.</ce:label><sb:reference><sb:contribution langtype="en"><sb:authors><sb:author><ce:surname>Reynolds</ce:surname><ce:given-name>JV</ce:given-name></sb:author><sb:author><ce:surname>Mercer</ce:surname><ce:given-name>P</ce:given-name></sb:author><sb:author><ce:surname>McDermott</ce:surname><ce:given-name>EWM</ce:given-name></sb:author><sb:author><ce:surname>Cross</ce:surname><ce:given-name>S</ce:given-name></sb:author><sb:author><ce:surname>Stokes</ce:surname><ce:given-name>M</ce:given-name></sb:author><sb:author><ce:surname>Murphy</ce:surname><ce:given-name>D</ce:given-name></sb:author><sb:author><ce:surname>O'Higgins</ce:surname><ce:given-name>NJ</ce:given-name></sb:author></sb:authors><sb:title><sb:maintitle>Audit of complete axillary dissection in early breast cancer</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Eur J Cancer</sb:maintitle></sb:title><sb:volume-nr>30A</sb:volume-nr></sb:series><sb:date>1994</sb:date></sb:issue><sb:pages><sb:first-page>148</sb:first-page><sb:last-page>149</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib30"><ce:label>30.</ce:label><sb:reference><sb:contribution langtype="en"><sb:authors><sb:author><ce:surname>Recht</ce:surname><ce:given-name>A</ce:given-name></sb:author><sb:author><ce:surname>Dongen JA</ce:surname><ce:given-name>van</ce:given-name></sb:author><sb:author><ce:surname>Fentiman</ce:surname><ce:given-name>IS</ce:given-name></sb:author><sb:author><ce:surname>Holland</ce:surname><ce:given-name>R</ce:given-name></sb:author><sb:author><ce:surname>Peterse</ce:surname><ce:given-name>JL</ce:given-name></sb:author></sb:authors></sb:contribution><sb:host><sb:edited-book><sb:title><sb:maintitle>Third meeting of the DCIS working party of the EORTC. Conference report</sb:maintitle></sb:title><sb:book-series><sb:series><sb:title><sb:maintitle>Eur J Cancer</sb:maintitle></sb:title><sb:volume-nr>30A</sb:volume-nr></sb:series></sb:book-series><sb:date>1994</sb:date></sb:edited-book><sb:pages><sb:first-page>1895</sb:first-page><sb:last-page>1901</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib31"><ce:label>31.</ce:label><sb:reference><sb:contribution langtype="en"><sb:authors><sb:author><ce:surname>Holland</ce:surname><ce:given-name>R.</ce:given-name></sb:author><sb:author><ce:surname>Hendriks</ce:surname><ce:given-name>JHCL</ce:given-name></sb:author><sb:author><ce:surname>Verbeek</ce:surname><ce:given-name>ALM</ce:given-name></sb:author><sb:author><ce:surname>Mravunac</ce:surname><ce:given-name>M</ce:given-name></sb:author><sb:author><ce:surname>Stekhoven</ce:surname><ce:given-name>JHS</ce:given-name></sb:author></sb:authors><sb:title><sb:maintitle>Extent, distribution, and mammographic/histological correlations of breast ductal carcinoma in situ</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Lancet</sb:maintitle></sb:title><sb:volume-nr>335</sb:volume-nr></sb:series><sb:date>1990</sb:date></sb:issue><sb:pages><sb:first-page>519</sb:first-page><sb:last-page>522</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib32"><ce:label>32.</ce:label><sb:reference><sb:contribution langtype="en"><sb:authors><sb:author><ce:surname>Ottesen</ce:surname><ce:given-name>GL</ce:given-name></sb:author><sb:author><ce:surname>Graversen</ce:surname><ce:given-name>HP</ce:given-name></sb:author><sb:author><ce:surname>Blichert-Toft</ce:surname><ce:given-name>M</ce:given-name></sb:author><sb:author><ce:surname>Zedeler</ce:surname><ce:given-name>K</ce:given-name></sb:author><sb:author><ce:surname>Andersen</ce:surname><ce:given-name>JA</ce:given-name></sb:author></sb:authors><sb:title><sb:maintitle>Ductal carcinoma in situ of the female breast</sb:maintitle></sb:title></sb:contribution><sb:host><sb:edited-book><sb:title><sb:maintitle>Short term results of a prospective nationwide study</sb:maintitle></sb:title><sb:book-series><sb:series><sb:title><sb:maintitle>Am J Surg Pathol</sb:maintitle></sb:title><sb:volume-nr>16</sb:volume-nr></sb:series></sb:book-series><sb:date>1992</sb:date></sb:edited-book><sb:pages><sb:first-page>1183</sb:first-page><sb:last-page>1196</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib33"><ce:label>33.</ce:label><sb:reference><sb:contribution langtype="en"><sb:authors><sb:author><ce:surname>Ottesen</ce:surname><ce:given-name>GL</ce:given-name></sb:author><sb:author><ce:surname>Graversen</ce:surname><ce:given-name>HP</ce:given-name></sb:author><sb:author><ce:surname>Blichert-Toft</ce:surname><ce:given-name>M</ce:given-name></sb:author><sb:author><ce:surname>Zedeler</ce:surname><ce:given-name>K.</ce:given-name></sb:author><sb:author><ce:surname>Andersen</ce:surname><ce:given-name>JA</ce:given-name></sb:author></sb:authors><sb:title><sb:maintitle>Lobular carcinoma in situ of the female breast</sb:maintitle></sb:title></sb:contribution><sb:host><sb:edited-book><sb:title><sb:maintitle>Short term results of a prospective nationwide study</sb:maintitle></sb:title><sb:book-series><sb:series><sb:title><sb:maintitle>Am J Surg Pathol</sb:maintitle></sb:title><sb:volume-nr>17</sb:volume-nr></sb:series></sb:book-series><sb:date>1993</sb:date></sb:edited-book><sb:pages><sb:first-page>14</sb:first-page><sb:last-page>21</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib34"><ce:label>34.</ce:label><sb:reference><sb:contribution langtype="en"><sb:authors><sb:author><ce:surname>Silverstein</ce:surname><ce:given-name>MJ</ce:given-name></sb:author></sb:authors><sb:title><sb:maintitle>Non-invasive breast cancer</sb:maintitle></sb:title></sb:contribution><sb:host><sb:edited-book><sb:title><sb:maintitle>The dilemma of the 1990's</sb:maintitle></sb:title><sb:book-series><sb:series><sb:title><sb:maintitle>Obstet Gynec Clin North Am</sb:maintitle></sb:title><sb:volume-nr>21</sb:volume-nr></sb:series></sb:book-series><sb:date>1994</sb:date></sb:edited-book><sb:pages><sb:first-page>639</sb:first-page><sb:last-page>658</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib35"><ce:label>35.</ce:label><sb:reference><sb:contribution langtype="en"><sb:authors><sb:author><ce:surname>Galea</ce:surname><ce:given-name>MH</ce:given-name></sb:author><sb:author><ce:surname>Blarney</ce:surname><ce:given-name>RW</ce:given-name></sb:author><sb:author><ce:surname>Elston</ce:surname><ce:given-name>CE</ce:given-name></sb:author><sb:author><ce:surname>Ellis</ce:surname><ce:given-name>IO</ce:given-name></sb:author></sb:authors><sb:title><sb:maintitle>The Nottingham prognostic index in primary breast cancer</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Breast Cancer Res Treat</sb:maintitle></sb:title><sb:volume-nr>22</sb:volume-nr></sb:series><sb:date>1992</sb:date></sb:issue><sb:pages><sb:first-page>207</sb:first-page><sb:last-page>219</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib36"><ce:label>36.</ce:label><sb:reference><sb:contribution langtype="en"><sb:authors><sb:author><ce:surname>Balslev</ce:surname><ce:given-name>I</ce:given-name></sb:author><sb:author><ce:surname>Axelsson</ce:surname><ce:given-name>CK.</ce:given-name></sb:author><sb:author><ce:surname>Zedeler</ce:surname><ce:given-name>K.</ce:given-name></sb:author><sb:author><ce:surname>Rasmussen</ce:surname><ce:given-name>BB</ce:given-name></sb:author><sb:author><ce:surname>Carstensen</ce:surname><ce:given-name>B</ce:given-name></sb:author><sb:author><ce:surname>Mouridsen</ce:surname><ce:given-name>HT</ce:given-name></sb:author></sb:authors><sb:title><sb:maintitle>The Nottingham prognostic index applied to 9,149 patients from the studies of the Danish Breast Cancer Cooperative Group (DBCG)</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Breast Cancer Res Treat</sb:maintitle></sb:title><sb:volume-nr>32</sb:volume-nr></sb:series><sb:date>1994</sb:date></sb:issue><sb:pages><sb:first-page>281</sb:first-page><sb:last-page>290</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib37"><ce:label>37.</ce:label><sb:reference><sb:contribution langtype="en"><sb:authors><sb:author><ce:surname>Rosselli</ce:surname><ce:given-name>del Turco M.</ce:given-name></sb:author><sb:author><ce:surname>Palli</ce:surname><ce:given-name>D</ce:given-name></sb:author><sb:author><ce:surname>Cariddi</ce:surname><ce:given-name>A</ce:given-name></sb:author><sb:author><ce:surname>Ciatto</ce:surname><ce:given-name>S</ce:given-name></sb:author><sb:author><ce:surname>Pacini</ce:surname><ce:given-name>P</ce:given-name></sb:author><sb:author><ce:surname>Distante</ce:surname><ce:given-name>V</ce:given-name></sb:author></sb:authors><sb:title><sb:maintitle>Intensive diagnostic follow-up after treatment of primary breast cancer</sb:maintitle></sb:title></sb:contribution><sb:host><sb:edited-book><sb:title><sb:maintitle>A randomized trial</sb:maintitle></sb:title><sb:book-series><sb:series><sb:title><sb:maintitle>JAMA</sb:maintitle></sb:title><sb:volume-nr>271</sb:volume-nr></sb:series></sb:book-series><sb:date>1994</sb:date></sb:edited-book><sb:pages><sb:first-page>1593</sb:first-page><sb:last-page>1597</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib38"><ce:label>38.</ce:label><sb:reference><sb:contribution langtype="en"><sb:authors><sb:collaboration>The GIVIO investigators</sb:collaboration></sb:authors><sb:title><sb:maintitle>Impact of follow-up testing on survival and health-related quality of life in breast cancer patients</sb:maintitle></sb:title></sb:contribution><sb:host><sb:edited-book><sb:title><sb:maintitle>A multicentre randomized controlled trial</sb:maintitle></sb:title><sb:book-series><sb:series><sb:title><sb:maintitle>JAMA</sb:maintitle></sb:title><sb:volume-nr>271</sb:volume-nr></sb:series></sb:book-series><sb:date>1994</sb:date></sb:edited-book><sb:pages><sb:first-page>1587</sb:first-page><sb:last-page>1592</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib39"><ce:label>39.</ce:label><sb:reference><sb:contribution langtype="en"><sb:authors><sb:author><ce:surname>Salvadori</ce:surname><ce:given-name>B.</ce:given-name></sb:author></sb:authors><sb:title><sb:maintitle>Local recurrences after breast-conserving treatment: an open problem</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Sem Surg Oncol</sb:maintitle></sb:title><sb:volume-nr>12</sb:volume-nr></sb:series><sb:date>1996</sb:date></sb:issue><sb:pages><sb:first-page>46</sb:first-page><sb:last-page>52</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib40"><ce:label>40.</ce:label><sb:reference><sb:contribution langtype="en"><sb:authors><sb:author><ce:surname>International Union Against Cancer, UICC</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Breast tumours (ICD-o 174)</sb:maintitle></sb:title></sb:contribution><sb:host><sb:edited-book><sb:editors><sb:editor><ce:surname>Hermanek</ce:surname><ce:given-name>P</ce:given-name></sb:editor><sb:editor><ce:surname>Sobin</ce:surname><ce:given-name>LH</ce:given-name></sb:editor></sb:editors><sb:title><sb:maintitle>TNM Classification of Malignant Tumours</sb:maintitle></sb:title><sb:edition>4th edn</sb:edition><sb:date>1987</sb:date><sb:publisher><sb:name>Springer-Verlag</sb:name><sb:location>Copenhagen</sb:location></sb:publisher></sb:edited-book><sb:pages><sb:first-page>93</sb:first-page><sb:last-page>99</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib41"><ce:label>41.</ce:label><sb:reference><sb:contribution langtype="en"><sb:authors><sb:author><ce:surname>Rutgers</ce:surname><ce:given-name>EJTh</ce:given-name></sb:author><sb:author><ce:surname>Peterse</ce:surname><ce:given-name>HL</ce:given-name></sb:author></sb:authors><sb:title><sb:maintitle>Future prospects for the staging of breast cancer</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Sem Surg Oncol</sb:maintitle></sb:title><sb:volume-nr>12</sb:volume-nr></sb:series><sb:date>1996</sb:date></sb:issue><sb:pages><sb:first-page>3</sb:first-page><sb:last-page>11</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib42"><ce:label>42.</ce:label><sb:reference><sb:contribution langtype="en"><sb:authors><sb:collaboration>EORTC Breast Cancer Cooperative Group</sb:collaboration></sb:authors></sb:contribution><sb:host><sb:edited-book><sb:book-series><sb:series><sb:title><sb:maintitle>Manual for Clinical Research in Breast Cancer</sb:maintitle></sb:title></sb:series></sb:book-series><sb:date>1991</sb:date><sb:publisher><sb:name>Leuven</sb:name><sb:location>Berlin</sb:location></sb:publisher></sb:edited-book><sb:pages><sb:first-page>1</sb:first-page><sb:last-page>106</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib43"><ce:label>43.</ce:label><sb:reference><sb:contribution langtype="en"><sb:authors><sb:author><ce:surname>Tagnon</ce:surname><ce:given-name>HJ</ce:given-name></sb:author></sb:authors><sb:title><sb:maintitle>Ethical considerations in controlled clinical trials</sb:maintitle></sb:title></sb:contribution><sb:host><sb:edited-book><sb:editors><sb:editor><ce:surname>Buyse</ce:surname><ce:given-name>ME</ce:given-name></sb:editor><sb:editor><ce:surname>Staquet</ce:surname><ce:given-name>MJ</ce:given-name></sb:editor><sb:editor><ce:surname>Sylvester</ce:surname><ce:given-name>RJ</ce:given-name></sb:editor></sb:editors><sb:title><sb:maintitle>Cancer Clinical Trials</sb:maintitle></sb:title><sb:book-series><sb:series><sb:title><sb:maintitle>Methods and Practice</sb:maintitle></sb:title></sb:series></sb:book-series><sb:date>1984</sb:date><sb:publisher><sb:name>Oxford University Press</sb:name></sb:publisher></sb:edited-book><sb:pages><sb:first-page>14</sb:first-page><sb:last-page>25</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib44"><ce:label>44.</ce:label><sb:reference><sb:contribution langtype="en"><sb:authors><sb:author><ce:surname>Buyse</ce:surname><ce:given-name>M</ce:given-name></sb:author></sb:authors><sb:title><sb:maintitle>Randomized clinical trails in surgical oncology</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Eur J Surg Oncol</sb:maintitle></sb:title><sb:volume-nr>17</sb:volume-nr></sb:series><sb:date>1991</sb:date></sb:issue><sb:pages><sb:first-page>421</sb:first-page><sb:last-page>428</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib45"><ce:label>45.</ce:label><sb:reference><sb:contribution langtype="en"><sb:authors><sb:author><ce:surname>Zelen</ce:surname><ce:given-name>M</ce:given-name></sb:author></sb:authors><sb:title><sb:maintitle>Randomized consent designs for clinical trials: an update</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Stat Med</sb:maintitle></sb:title><sb:volume-nr>9</sb:volume-nr></sb:series><sb:date>1990</sb:date></sb:issue><sb:pages><sb:first-page>645</sb:first-page><sb:last-page>656</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference></ce:bibliography-sec></ce:bibliography></tail></article></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Principles and guidelines for surgeons—management of symptomatic breast cancer</title></titleInfo><titleInfo type="alternative" lang="en" contentType="CDATA"><title>Principles and guidelines for surgeons—management of symptomatic breast cancer</title></titleInfo><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Blichert-Toft</namePart><affiliation>Department of Surgery, Rigshospitalet, Copenhagen, Denmark</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.G.</namePart><namePart type="family">Smola</namePart><affiliation>Universität Klinik für Chirurgie, Karl Franzens Universität, Graz, Austria</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">L.</namePart><namePart type="family">Cataliotti</namePart><affiliation>Clinica Chirurgica I, University of Florence, Italy</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">N.</namePart><namePart type="family">O'Higgins</namePart><affiliation>University College, Dublin, Ireland</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="review-article" displayLabel="Review article"></genre><originInfo><publisher>ELSEVIER</publisher><dateIssued encoding="w3cdtf">1997</dateIssued><copyrightDate encoding="w3cdtf">1997</copyrightDate></originInfo><language><languageTerm type="code" authority="iso639-2b">eng</languageTerm><languageTerm type="code" authority="rfc3066">en</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType></physicalDescription><abstract lang="en">The European Society of Surgical Oncology is actively involved in the promotion of a high standard of surgical oncology throughout Europe. Such an ambition involves recognition of Centres of Excellence in the management of cancer patients throughout Europe. These centres have a multi-disciplinary system involved in the total care of patients with cancer and are concerned with the delivery of care to the highest available standards. It is accepted that not all patients with cancer can, nor should, necessarily be treated in such highly specialized centres. Yet all cancer patients should be guaranteed a high standard of care. High surgical standards can be ensured if surgeons treating cancer are trained in specialist centres and, when in independent practice, follow established guidelines or protocols of treatment. In common with many national surgical oncology societies, the European Society of Surgical Oncology is in the process of establishing good practice guidelines in the treatment of solid tumours. This document on the management of symptomatic breast cancer is the first of a series of guidelines to be proposed by ESSO. It draws heavily on excellent documents already in existence from the British Association of Surgical Oncology and from the Danish Breast Cancer Co-Operative Group. It is hoped that this document will be sufficiently clear and purposeful to be of help to the individual surgeon and yet sufficiently flexible to allow it to be adopted in the different medical systems throughout Europe.</abstract><note>On behalf of the European Society of Surgical Oncology</note><note type="content">Section title: Review</note><relatedItem type="host"><titleInfo><title>European Journal of Surgical Oncology</title></titleInfo><titleInfo type="abbreviated"><title>YEJSO</title></titleInfo><genre type="Journal">journal</genre><originInfo><dateIssued encoding="w3cdtf">199704</dateIssued></originInfo><identifier type="ISSN">0748-7983</identifier><identifier type="PII">S0748-7983(00)X0073-X</identifier><part><date>199704</date><detail type="volume"><number>23</number><caption>vol.</caption></detail><detail type="issue"><number>2</number><caption>no.</caption></detail><extent unit="issue pages"><start>101</start><end>190</end></extent><extent unit="pages"><start>101</start><end>109</end></extent></part></relatedItem><identifier type="istex">4CA14B6514830F0908CC91146C55ABB34598516B</identifier><identifier type="DOI">10.1016/S0748-7983(97)80001-7</identifier><identifier type="PII">S0748-7983(97)80001-7</identifier><identifier type="ArticleID">97800017</identifier><accessCondition type="use and reproduction" contentType="">© 1997W.B. Saunders Company Limited</accessCondition><recordInfo><recordContentSource>ELSEVIER</recordContentSource><recordOrigin>W.B. Saunders Company Limited, ©1997</recordOrigin></recordInfo></mods></metadata></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Ticri/CIDE/explor/TelematiV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002D28 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 002D28 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Ticri/CIDE
|area= TelematiV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:4CA14B6514830F0908CC91146C55ABB34598516B
|texte= Principles and guidelines for surgeons—management of symptomatic breast cancer
}}
| This area was generated with Dilib version V0.6.31. |  |